(Q48317251)

10 February 2018

title

Na+,K+-ATPase interaction with a brain endogenous inhibitor (endobain E). (English)

1 reference

10 February 2018

author name string

Rodríguez de Lores Arnaiz G

1

1 reference

10 February 2018

Reinés A

2

1 reference

10 February 2018

Herbin T

3

1 reference

10 February 2018

Peña C

4

1 reference

10 February 2018

publication date

1 November 1998

1 reference

10 February 2018

Neurochemistry International

published in

1 reference

10 February 2018

volume

33

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

425-433

1 reference

10 February 2018

Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+, K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

SODIUM-POTASSIUM-ACTIVATED ATPase AND POTASSIUM-ACTIVATED p-NITROPHENYLPHOSPHATASE: A COMPARISON OF THEIR SUBCELLULAR LOCALIZATIONS IN RAT BRAIN

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Effect of Na+, K+-ATPase modifiers on high-affinity ouabain binding determined by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Influence of extracellular K+ concentration on the time-course of Na+/K+-ATPase inhibition by cardiac glycosides with fast and low binding kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

A synthetic peptide with morphine-like pharmacologic action

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Identification and characterization of a ouabain-like compound from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Isolation and characterization of a sodium pump inhibitor from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

A study on the influence of the concentration of Mg 2+ , P i , K + , Na + , and Tris on (Mg 2+ + P i )-supported g-strophanthin binding to (Na + = K + )activated ATPase from ox brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Kinetics of Na+, K+-ATPase inhibition by a rat brain endogenous factor (II-E).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Endogenous ‘ouabain like’ activity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Mass spectral characterization of an endogenous digitalislike factor from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Differential properties between an endogenous brain Na+, K(+)-ATPase inhibitor and ouabain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

In search of synaptosomal Na+,K(+)-ATPase regulators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

An endogenous factor which interacts with synaptosomal membrane Na+, K(+)-ATPase activation by K+.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Partial characterization of an endogenous factor which modulates the effect of catecholamines on synaptosomal Na+, K+-ATPase.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

The aging of a brain soluble fraction modifies its effect on the activity of neuronal Na+, K+-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Characterization of synaptosomal membrane Na+, K(+)-ATPase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Ultrastructural and enzymic studies of cholinergic and non-cholinergic synaptic membranes isolated from brain cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Different properties of two brain extracts separated in Sephadex G-50 that modify synaptosomal ATPase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Kinetics of Na+,K(+)-ATPase inhibition by brain endobains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

The Na,K-ATPase of nervous tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2898%2900046-1

7 January 2021

10.1016/S0197-0186(98)00046-1

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018